The number of people in the UK who have died after taking drugs for diabetes and weight loss has risen to 82, according to new figures from the country’s medicines regulator.
The Medicines and Healthcare Products Regulatory Agency (MHRA) revealed the death toll associated with the use of GLP-1RA receptor agonist drugs such as Mounjaro, Wegovy and Ozempic, up to 31 January.
It included 22 deaths where the deceased person was using the drugs to lose weight - an increase from 10 in October as the drugs continue rise in popularity.
The figures come from medical reports that record adverse incidents with medicines. However, usage may have been coincidental to a death rather than responsible for it, and an underlying illness unrelated to the drug could have also played a role.
As of January, the MHRA had received reports of 18 deaths associated with tirzepatide, commercially known as Mounjaro; 29 deaths associated with semaglutide which has the brand names Ozempic, Rybelsus and Wegovy; and 35 deaths associated with single-constituent liraglutide more commonly known as Saxenda or Victoza.
These drugs have rapidly increased in popularity and regulators have scrambled to ensure they are handed out appropriately with the pharmacy watchdog tightening rules around how the drugs are prescribed.
Source: The Independent, 24 February 2025
Recommended Comments
Create an account or sign in to comment